Halozyme Therapeutics Inc
Open
SectorHealthcare
78.99 2.56
Overview
Share price change
24h
Min
76.61
Max
79.15
Income | 292M 150M |
|---|---|
Sales | -75M 377M |
P/E Sector Avg | 26.302 56.269 |
EPS | 1.221 |
Profit margin | 39.832 |
Employees | 423 |
EBITDA | -62M 220M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +5.18% upside |
Next Earnings | 4 Aug 2026 |
|---|
Market Cap | 1.2B 8.9B |
|---|---|
Previous open | 76.43 |
Previous close | 78.99 |
News Sentiment
By Acuity
50%
50%
140 / 342 Healthcare
Halozyme Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Halozyme Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 81 USD 5.18%
High 96 USD
Low 57 USD
Based on 6 Wall Street analysts offering 12 month price targets forHalozyme Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$